Back to search

Article

Synergistic effect of deoxynucleosides and AAV gene therapy for thymidine kinase 2 deficiency

2020-10-08

Abstract excerpt

Autosomal recessive thymidine kinase 2 ( TK2 ) mutations causes TK2 deficiency, which typically manifests as a progressive and fatal mitochondrial myopathy in infants and children. Treatment with deoxycytidine and thymidine ameliorates mitochondrial defects and extends lifespan of Tk2 knock-in mouse (TK2 −/− ); however, efficacy is limited by age- and tissue-dependent expression of the cytosolic enzymes Tk1 and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32b57e8f-2d04-58c1-9787-728bb5dacfd9
DOI
10.1101/2020.10.08.330969
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergistic effect of deoxynucleosides and AAV gene therapy for thymidine kinase 2 deficiencyDOI 10.1101/2020.10.08.330969
Select a neighboring publication to make it the new centre.